- $5.26bn
- $5.65bn
- €1.19bn
Stevanato Group SpA reports results for the quarter ended in December - Earnings Summary
Brief: Stevanato Group Says Signed Extension To Licensing Agreement With Haselmeier For Axis-D Pen Injector Technology
NYSE ORDER IMBALANCE 55218.0 SHARES ON BUY SIDE
Vaccine vial maker Stevanato ticks up 2021 guidance after Q3 results
Stevanato Group SpA reports results for the quarter ended in September - Earnings Summary
U.S. RESEARCH ROUNDUP-Altice USA, Kinnate Biopharma, Omeros
U.S. RESEARCH ROUNDUP- Altice USA, Kinnate Biopharma, Omeros
U.S. RESEARCH ROUNDUP-Aprea Therapeutics, Duke Energy, Inovalon Holdings
Vaccine vial maker Stevanato to fund new plants, M&A with IPO money -chairman
U.S. STOCKS ON THE MOVE-Autoliv, Corvus Pharma, BioNTech, Turquoise Hill Resources